2024 |
Sarepta Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Cassava Sciences Inc
|
Chairman of the board |
- |
- |
2023 |
Sarepta Therapeutics Inc
|
Independent Director |
553.3 K |
-0.0 % |
2023 |
Cassava Sciences Inc
|
Independent Director |
- |
- |
2022 |
Sarepta Therapeutics Inc
|
Independent Director |
553.4 K |
-5.6 % |
2022 |
Chemomab Therapeutics Ltd - ADR
|
Independent Director |
123 K |
-19.1 % |
2022 |
Gain Therapeutics Inc
|
Independent Director |
69.8 K |
-36.9 % |
2021 |
Sarepta Therapeutics Inc
|
Independent Director |
586.1 K |
11.7 % |
2021 |
Chemomab Therapeutics Ltd - ADR
|
Independent Director |
152 K |
- |
2021 |
Gain Therapeutics Inc
|
Independent Director |
110.6 K |
- |
2020 |
Sarepta Therapeutics Inc
|
Independent Director |
524.9 K |
-6.5 % |
2020 |
Chemomab Therapeutics Ltd - ADR
|
Independent Director |
- |
- |
2020 |
Gain Therapeutics Inc
|
Independent Director |
- |
- |
2019 |
Sarepta Therapeutics Inc
|
Independent Director |
561.3 K |
20.8 % |
2018 |
Sarepta Therapeutics Inc
|
Independent Director |
464.5 K |
55.1 % |
2017 |
Sarepta Therapeutics Inc
|
Independent Director |
299.5 K |
51.6 % |
2016 |
Sarepta Therapeutics Inc
|
Independent Director |
197.5 K |
-7.3 % |
2015 |
Sarepta Therapeutics Inc
|
Independent Director |
213.1 K |
- |
2014 |
Sarepta Therapeutics Inc
|
Independent Director |
- |
- |